Stephan Schwers
Stephan Schwers publishes mostly in Hematology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, on topics such as Coagulation, Bradykinin, Polyphosphates, and Angioedema, Blood Coagulation and Thrombosis Mechanisms and Hemophilia Treatment and Research.
- World rank
- #486,254 of 7,710,434 ranked researchers
- Rank in Germany
- #23,904 of 364,343
- Works
- 32
- Citations
- 1.7k
- Citations per work
- 52.8
What does Stephan Schwers research?
Stephan Schwers's work is mostly in Medicine (69%), Immunology and Microbiology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2268.8%
- Medicine2268.8%
- Everything else720.8%
- Life Sciences310.4%
- 1Hematology22% of their works
- 2Cardiology and Cardiovascular Medicine16% of their works
- 3Pulmonary and Respiratory Medicine12% of their works
- 4Genetics12% of their works
- 5Immunology10% of their works
- 6Internal Medicine8% of their works
Research topics
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Blood Coagulation and Thrombosis Mechanisms
- Hemophilia Treatment and Research
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Protease and Inhibitor Mechanisms
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Which keywords describe Stephan Schwers's research?
The keywords of their largest research topics: Antithrombotic Therapy, Prophylaxis, Hereditary Angioedema, Kinin Receptor Family, Protease-Activated Receptors, Thrombin, Factor VIII and Hemophilia.
- Tissue Inhibitors of Metalloproteinases
- Natural Killer Cells
- Matrix Metalloproteinases
- Atrial Fibrillation
- Venous Thromboembolism
- Hemophilia
- Thrombin
- Kinin Receptor Family
- Prophylaxis
- Antithrombotic Therapy
- Hereditary Angioedema
- Protease-Activated Receptors
- Factor VIII
- Pulmonary Embolism
- Anticoagulant Therapy
- Foxp3
- NK Cell Recognition
- TGF-ß
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Antithrombotic Therapy182 topics
- Prophylaxis172 topics
- Hereditary Angioedema101 topic
- Kinin Receptor Family101 topic
- Protease-Activated Receptors101 topic
- Thrombin101 topic
- Factor VIII91 topic
- Hemophilia91 topic
- Pulmonary Embolism81 topic
- Venous Thromboembolism81 topic
- Anticoagulant Therapy71 topic
- Atrial Fibrillation71 topic
- Foxp331 topic
- Matrix Metalloproteinases31 topic
- NK Cell Recognition31 topic
- Natural Killer Cells31 topic
- TGF-ß31 topic
- Tissue Inhibitors of Metalloproteinases31 topic
Where does Stephan Schwers work?
Stephan Schwers's main affiliation in the publication record is Bayer (Germany), Germany.
How many publications and citations does Stephan Schwers have?
OpenAlex counts 32 works and 1,688 citations for Stephan Schwers, an h-index of 16, ranking #486,254 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Stephan Schwers. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.